This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ReNeuron Group plc
Drug Names(s): ReN003 stem cell therapy, human retinal precursor cells (hRPCs)
Description: ReN003 cell therapy consists of human retinal precursor cells (hRPCs) that have been generated using ReNeuron's proprietary cell expansion and cell selection technologies.
Additional information available to subscribers only: